ISTA PHARMACEUTICALS INC
POS AM, EX-23.1, 2000-08-16
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ISTA PHARMACEUTICALS INC, POS AM, 2000-08-16
Next: EDISON MISSION ENERGY, U-57, 2000-08-16



<PAGE>   1

                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the references to our firm under the captions "Selected Financial
Data" and "Experts" and to the use of our reports dated March 29, 2000, with
respect to the financial statements of ISTA Pharmaceuticals, Inc., and March 8,
2000, with respect to the financial statements of Visionex Pte. Ltd., in
Post-Effective Amendment No. 2 to the Registration Statement (Form S-1) and
related Prospectus of ISTA Pharmaceuticals, Inc. for the registration of shares
of its common stock.


                                          /s/ ERNST & YOUNG LLP

San Diego, California

August 16, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission